Advanced in Defective Apolipoprotein B-100

Alexandra I. Ershova

Moscow, MOW, RU 
Advanced in Defective Apolipoprotein B-100
Moscow, MOW, RU 
OverviewLocationsClinical Research

Overview

Alexandra Ershova practices in Moscow, Russian Federation. Ms. Ershova is rated as an Advanced expert by MediFind in the treatment of Defective Apolipoprotein B-100. Her top areas of expertise are Hyperlipidemia Type 3, Familial Hypercholesterolemia, High Cholesterol, and Endocardial Fibroelastosis.

Her clinical research consists of co-authoring 31 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 6 articles and participated in 1 clinical trial in the study of Defective Apolipoprotein B-100.

Gender
Female

Locations

Moscow, MOW 101000, Russian Federation

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Impact of Genetic Testing and Motivational Counseling on the Adherence to Healthy Lifestyle and Hypolipidemic Therapy and Efficiency of Cascade Screening in Patients With Familial Hypercholesterolemia (GENMOTIV-FH)
Impact of Genetic Testing and Motivational Counseling on the Adherence to Healthy Lifestyle and Hypolipidemic Therapy and Efficiency of Cascade Screening in Patients With Familial Hypercholesterolemia (GENMOTIV-FH)
Enrollment Status: Active_not_recruiting
Publish Date: December 17, 2024
Intervention Type: Genetic, Diagnostic test, Behavioral, Other
Study Phase: Not Applicable
Retrospective Observational Study of the Efficacy and Safety of Statin Monotherapy or Statins in Combination With Ezetimibe in Patients Receiving Lipid-lowering Therapy in Both Primary and Secondary Prevention of CVD
Retrospective Observational Study of the Efficacy and Safety of Statin Monotherapy or Statins in Combination With Ezetimibe in Patients Receiving Lipid-lowering Therapy in Both Primary and Secondary Prevention of CVD
Enrollment Status: Completed
Publish Date: January 12, 2023
Intervention Type: Drug
View 1 Less Clinical Trial

31 Total Publications

Genetic and Metabolic Factors of Familial Dysbetalipoproteinemia Phenotype: Insights from a Cross-Sectional Study.
Genetic and Metabolic Factors of Familial Dysbetalipoproteinemia Phenotype: Insights from a Cross-Sectional Study.
Journal: International journal of molecular sciences
Published: June 18, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Ershova's expertise for a condition
ConditionClose
    View All 14 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile